Introduction
============

Obesity is characterized by a state of chronic, low-grade inflammation (Hotamisligil, [@B27]) with features like an increased production of chemokines and inflammatory cytokines including tumor necrosis factor alpha (TNFα), interleukin-6 (IL6), and monocyte chemoattractant protein-1 (MCP-1; Shoelson et al., [@B53]). Another feature is the activation of inflammatory signaling pathways including inhibitor of NF-κB kinase beta (IKK-β) and c-Jun NH2-terminal kinase (JNK; Yuan et al., [@B78]; Hirosumi et al., [@B25]). The leading role for these inflammatory pathways in the development of obesity-associated insulin resistance was demonstrated by several loss of function studies (Arkan et al., [@B2]; Solinas et al., [@B55]).

It is evident that macrophages infiltrate human and murine adipose tissue with increasing body weight (Weisberg et al., [@B66]; Xu et al., [@B74]). Nevertheless, the pathogenic mechanisms leading to macrophage accumulation in the obese state are still not completely understood. Several hypotheses arose during the last decade. Local hypoxia (Hosogai et al., [@B26]; Halberg et al., [@B21]), fat cell apoptosis (Fischer-Posovszky et al., [@B15]) as well as adipocyte hypertrophy, oxidative stress, or endoplasmic reticulum stress (Furukawa et al., [@B16]; Ozcan et al., [@B46]; Gregor and Hotamisligil, [@B20]; Skurk et al., [@B54]; Wood et al., [@B70]) might trigger macrophage infiltration into obese adipose tissue.

Adipose tissue macrophages secrete inflammatory cytokines thereby inducing local and systemic inflammation. Furthermore, they stimulate expression and secretion of inflammatory cytokines in fat cells. Therefore, adipocytes themselves, in addition to macrophages, are involved in obesity-induced inflammation and insulin resistance.

Understanding how adipocytes and macrophages interact on a cellular and molecular level will contribute to shed light on adipose tissue inflammation. Furthermore, it will extend the knowledge about insulin resistance in adipocytes and might help to uncover new pharmacological targets for treatment options. For this purpose, cell culture techniques offer almost unlimited possibilities and help to gain first insights into interaction and underlying molecular mechanisms. Moreover, they may be perfectly suited to highlight species differences observed between rodents and man. This review shortly summarizes existing *in vitro* model systems for the inflamed adipose tissue, most of them being murine, and introduces a new human model system, i.e., THP-1 macrophages and the unique Simpson--Golabi--Behmel syndrome (SGBS) cell strain.

The Past -- Summary of Existing Model Systems
=============================================

The first studies which investigated the effects of macrophage-secreted factors on adipocyte biology were carried out in the 1980s (Pekala et al., [@B47]). Back then Pekala et al. ([@B47]) used conditioned media from macrophages to stimulate murine 3T3-L1 cells. Despite its simplicity this powerful and useful cell culture tool was almost forgotten. In the last decade, however, it became clear that the obesity-associated macrophage infiltration into adipose tissue contributes to obesity-associated health risks especially insulin resistance. This new perspective stimulated studies on the biological interaction of adipocytes and macrophages. Several research groups rediscovered "the old" experimental setup and found it very useful to study adipose tissue inflammation *in vitro*. A summary of typically used combinations of cellular models is given in Table [1](#T1){ref-type="table"}.

###### 

***In vitro* models (conditioned media, indirect, or direct co-cultures) for studying the inflammatory process in adipose tissue**.

  Adipocyte model   Macrophage model   Reference             
  ----------------- ------------------ ----------- --------- -------------------------------------------------------------------------------------------------------------------------------------------------
  Murine            3T3-L1             Murine      RAW264    Lumeng et al. ([@B37]), Molgat et al. ([@B41]), Hirai et al. ([@B23])
  Murine            3T3-L1             Murine      J774.A1   Yarmo et al. ([@B76]), Lu et al. ([@B35]), Ide et al. ([@B29]), Molgat et al. ([@B42])
  Murine            3T3-L1             Murine      C2D       Xie et al. ([@B73])
  Murine            3T3-L1             Murine      Primary   Hirasaka et al. ([@B24]), Suganami et al. ([@B57]), Toyoda et al. ([@B60]), Kennedy et al. ([@B30])
  Murine            3T3-L1             Human       THP-1     Unoki et al. ([@B64]), Constant et al. ([@B10])
  Murine            3T3-F442A          Murine      RAW264    Tanaka et al. ([@B59])
  Murine            OP9                Human       U937      Xiao et al. ([@B72])
  Murine            Primary            Murine      RAW264    Sakurai et al. ([@B50]), Chang et al. ([@B6])
  Human             Primary            Human       THP-1     Constant et al. ([@B9]), Bassols et al. ([@B3]), Bouwman et al. ([@B4]), Gao et al. ([@B17]), Miranville et al. ([@B40]), Yarmo et al. ([@B75])
  Human             Primary            Human       U937      Bumrungpert et al. ([@B5]), Overman et al. ([@B45]), Samuvel et al. ([@B51])
  Human             Primary            Human       Primary   Lacasa et al. ([@B34]), Keophiphath et al. ([@B31]), Chazenbalk et al. ([@B7])

3T3-L1 adipocytes and murine macrophages such as RAW264 or J774 are the most commonly used combinations. Several studies provided important insights on how macrophages or macrophage-secreted factors induce insulin resistance in adipocytes on a cellular level (Constant et al., [@B9]; Permana et al., [@B48]). In addition, these systems helped to identify signaling pathways contributing to the development of insulin resistance (Lumeng et al., [@B37]; Constant et al., [@B10]). However, murine 3T3-L1 adipocytes are aneuploid (Gregoire et al., [@B19]) and behave different than human adipocytes in some regards. For instance, murine 3T3-L1 cells and human SGBS cells show different sensitivity toward apoptosis induction. While 3T3-L1 preadipocytes and adipocytes are sensitive to apoptosis induction by serum deprivation (Magun et al., [@B38]), human SGBS preadipocytes and adipocytes and also human primary adipocytes are characterized by a general resistance to apoptosis stimuli including serum withdrawal (Fischer-Posovszky et al., [@B14]). While macrophage-conditioned media stimulated Akt phosphorylation in 3T3-L1 cells (Molgat et al., [@B42]), Akt phosphorylation was inhibited in our human model system (Keuper et al., [@B32]) further supporting the differences between murine and human cells.

Additionally, murine and human macrophages display differences (Mestas and Hughes, [@B39]). In particular, expression of surface molecules is slightly different. In contrast to humans, murine adipose tissue macrophages are characterized by a low CD14 expression (Lumeng et al., [@B36]). Furthermore, there has been considerable controversy as to whether human macrophages express inducible NO synthase (iNOS; Schneemann and Schoedon, [@B52]). Studies suggest different iNOS activity in macrophage populations in murine versus human models of inflammation (Zhang et al., [@B79]; Schneemann and Schoedon, [@B52]; Lumeng et al., [@B36]).

Experimental alternatives are scarce when it comes to human physiology. Some groups used human primary adipocytes in combination with human macrophage cell lines or primary macrophages. This approach has the advantage of being very close to human physiology and helps to identify inter-individual variations. On the other hand, the usage of human primary material has several limitations. Availability of tissue samples is restricted and related to ethical issues. Techniques for the preparation of human preadipocytes/adipocytes are sophisticated and time-consuming. As a consequence, these cells are expensive when obtained from a commercial source. Fat cells *ex vivo* have a limited survival time, and preadipocytes loose their capacity for adipogenic differentiation after only a few passages *in vitro*. Inter-individual differences might also be prejudicial for some applications, where a high reproducibility of results is indispensable. Especially when needed for instance for large-scale drug testing, human primary preadipocytes or adipocytes no longer provide a useful model system.

Therefore we aimed at developing a model system of inflamed adipose tissue using a human preadipocyte cell strain assuring sufficient starting material, easy handling, and high reproducibility.

In 2001 we introduced the human SGBS cell strain, which is characterized by a high capacity for *in vitro* differentiation (Wabitsch et al., [@B65]). SGBS preadipocytes are cultured in DMEM/Ham's F12 (1:1) containing 33 μM biotin, 17 μM pantothenate, antibiotics (serum-free, basal medium), and 10% FCS and adipogenic differentiation is induced after reaching near confluence as described previously (Fischer-Posovszky et al., [@B12]). Up till generation 50 the cells retain their ability for adipogenic differentiation. Additionally, once they are differentiated they function and behave as primary isolated human fat cells. They show a typical fat cell-specific metabolism including insulin-stimulated glucose uptake, and *de novo* lipogenesis (Fischer-Posovszky et al., [@B13]). Furthermore, β-adrenergic stimuli activate lipolysis and SGBS adipocytes express and secrete adipokines including leptin, adiponectin, and RBP4 (Fischer-Posovszky et al., [@B13]).

Some studies on human inflamed adipose tissue using SGBS cells
--------------------------------------------------------------

Since the first publication, SGBS cells have been spread to several laboratories all over the world. Many successfully published studies demonstrate the power and utility of the SGBS cell strain. It provides an almost unlimited source of homogeneous human preadipocytes with high differentiation capacity (Fischer-Posovszky et al., [@B13]). SGBS cells are broadly used to study adipogenic differentiation or effects of drugs and food compounds on fat cell function. However, few studies have focused on inflammation.

Permana et al. ([@B49]) used SGBS adipocytes in combination with human U937 cells. The U937 cell line represents a well characterized model for human macrophages. Expression and secretion of inflammatory cytokines were highly increased and adiponectin expression and secretion was reduced, when SGBS cells were treated with U937--macrophage-conditioned medium (MacCM; Permana et al., [@B49]). Additionally, they showed an increased lipolytic activity of adipocytes after exposure to macrophage-secreted factors (Permana et al., [@B49]). Lipolysis might locally aggravate the pro-inflammatory process by releasing FFA which in turn exert pro-inflammatory effects on macrophages and adipocytes (Suganami et al., [@B58]). These adverse effects of macrophage-secreted factors on fat cells were ameliorated or even diminished by treatment with pioglitazone, an insulin-sensitizing thiazolidinedione (Permana et al., [@B49]). SGBS cells in combination with U937--MacCM were also used to perform microarray analysis (O'Hara et al., [@B44]). About 1088 transcripts were up- or down-regulated by treatment with macrophage-secreted factors and the authors validated selected genes by real-time PCR (O'Hara et al., [@B44]). Several matrix metalloproteinase were up-regulated including MMP1, MMP3, MMP9, MMP10, MMP12, and MMP19 and also accumulated in the medium supernatants. The authors concluded from this study that macrophages contribute to tissue remodeling processes in obese adipose tissue (O'Hara et al., [@B44]).

Another possibility is the usage of human primary macrophages isolated from blood. Even more elegantly, Wentworth et al. ([@B67]) isolated macrophages from human adipose tissue samples. They performed collagenase digestion to isolate stromal vascular cells from adipose tissue and then used a flow cytometry cell sorting strategy to collect CD11^+^--macrophages. The *ex vivo* culture of human adipose tissue macrophages is certainly very close to human physiology and well suited to identify patient-specific characteristics. Using this strategy, the authors found that only CD11c^+^--macrophages and not CD11c^−^--macrophages induce insulin resistance in SGBS fat cells (Wentworth et al., [@B67]).

Overnutrition and hypoxia were discussed as factors initiating macrophage infiltration into adipose tissue in the obese state (Trayhurn and Wood, [@B61]; Hosogai et al., [@B26]). Both processes were studied in the SGBS cell system. High doses of glucose or saturated fatty acids were reported to induce expression of chemoattractants like serum amyloid A (SAA) or MCP-1 (Yeop Han et al., [@B77]). Hypoxia led to robust changes in mRNA expression in SGBS adipocytes (Geiger et al., [@B18]).

The Present -- Establishing a Human System with High Reproducibility and Almost Unlimited Availability
======================================================================================================

Experimental setup for a human *in vitro* model system of inflamed adipose tissue
---------------------------------------------------------------------------------

We tested three different, human monocytic cell lines (U937, MonoMac6, THP-1). The THP-1 cell line was most suitable due to easy handling and a macrophage-like phenotype after *in vitro* differentiation presumably very similar to human adipose tissue macrophages *in vivo*. THP-1 is a well described cell line and commonly used as a model for human macrophages (Tsuchiya et al., [@B63]). THP-1 cells are cultured in RPMI containing 100 μM non-essential amino acids, 2 mM [l]{.smallcaps}-glutamine, 1 mM sodium pyruvate, antibiotics (basal medium), and 10% FCS. We induced differentiation of THP-1 cells into macrophages by incubation with 125 ng/ml phorbol myristate acetate (PMA) for 48 h in serum-free basal medium. We characterized the differentiation process *in extenso*. For example, the expression of macrophage-specific surface molecules such as CD11c, CD54, CD86 as well as production and secretion of inflammatory cytokines is dramatically increased after differentiation into macrophages (Tsuchiya et al., [@B62]; Keuper et al., [@B32]). Most conveniently, the differentiation from monocytes to macrophages goes along with a marked change in morphology. While THP-1 monocytes grow in suspension, THP-1 macrophages adhere to the culture dishes and remain adherent. Thus, the differentiation process can be easily controlled and monitored.

Combining SGBS cells with THP-1 cells creates a perfect human model system with unlimited availability. Both cell types can be used as precursors (monocytes, preadipocytes) or differentiated into their final phenotype (macrophages, adipocytes; Figure [1](#F1){ref-type="fig"}A). This system can be used to study endocrine effects by using just the conditioned medium or a transwell co-culture system. Cellular interactions can be monitored by a direct co-culture system (Figure [1](#F1){ref-type="fig"}B). For the use of conditioned media, *in vitro* differentiated THP-1 cells (10^6^/ml) were incubated with serum-free basal medium to achieve chemically well-defined conditions. In addition, 0.5% bovine serum albumin (BSA) is added to stabilize macrophage-secreted factors. Macrophage-conditioned media (MacCM) were collected after 48 h and cleared by centrifugation. For a direct co-culture system, THP-1 macrophages were added directly to cultures of SGBS cells at increasing rates (THP-1:SGBS 1:10, 1:2, 1:1, 2:1). SGBS cells and THP-1 cells show optimal growth in distinct cell culture media (THP-1: RPMI, SGBS: DMEM-F12). To exclude effects caused by the cell culture medium, we used serum-free THP-1 medium containing 0.5% BSA in corresponding concentrations as vehicle control for the cell-free as well as the direct co-culture system.

![**Experimental setup**. **(A)** We designed an experimental setup to mimic adipose tissue inflammation *in vitro*. Human THP-1 cells were either used as monocytes or differentiated into macrophages by incubation with 125 ng/ml PMA (phorbol-12 myristate 13-acetate). We used monocyte-conditioned (MonCM) and macrophage-conditioned media (MacCM) which were collected for 48 h in serum-free medium. In a direct co-culture system (CoCult) macrophages were directly added to cultures of human SGBS preadipocytes and adipocytes. **(B)** Immunofluorescence of SGBS control cultures and co-cultures of SGBS and THP-1 macrophages stained with CD11c-PE, BODIPY, and DAPI.](fendo-02-00089-g001){#F1}

Functional characterization of the model system
-----------------------------------------------

Adipose tissue inflammation is one of the key elements in the pathogenesis of obesity-related insulin resistance. This has been shown by several animal and human studies including *in vivo* and *in vitro* investigations (Yuan et al., [@B78]; Hirosumi et al., [@B25]; Arkan et al., [@B2]; Solinas et al., [@B55]). Macrophages or macrophage-secreted factors inhibit several insulin-stimulated processes of preadipocytes and adipocytes. The inhibition of adipogenic differentiation was demonstrated in the above mentioned murine model system as well as in primary isolated preadipocytes (Constant et al., [@B9]; Yarmo et al., [@B75]). As this effect was well characterized, we used it as a positive control for the initial characterization of our SGBS/THP-1 system. We differentiated SGBS cells for 10 days in the presence of MacCM or vehicle. Fresh MacCM was added to the differentiation medium with each medium change. Analyzing the lipid content of the resulting cell cultures, we found a complete inhibition of adipogenic differentiation as judged morphologically by the absence of intracellular lipid droplets (Figure [2](#F2){ref-type="fig"}A). A Nile Red staining confirmed this finding (Figure [2](#F2){ref-type="fig"}B). In parallel, the expression of the adipocyte marker gene PPARγ was diminished as assessed by quantitative real-time PCR (Figure [2](#F2){ref-type="fig"}C). For the co-culture system, *in vitro* differentiated THP-1 macrophages supplied in adipogenic differentiation medium were added directly to cultures of SGBS cells. In line with findings from MacCM, the direct co-culture system resulted in a dose-dependent inhibition of the adipogenic differentiation process (Figures [2](#F2){ref-type="fig"}D,E) The ratio of one macrophage to 10 SGBS cells is well achievable in the *in vivo* situation. Around 10% macrophages were detected in human adipose tissue samples of obese subjects by immunohistochemistry (Harman-Boehm et al., [@B22]). Notably, macrophages accumulate around dead, apoptotic fat cells suggesting a locally increased macrophage:fat cell ratio (Cinti et al., [@B8]; Alkhouri et al., [@B1]; Keuper et al., [@B32]).

![**Effect of macrophage-conditioned medium (MacCM) and co-culture on adipogenic differentiation**. **(A)** SGBS preadipocytes were incubated with MacCM (10, 20, 50%) or vehicle during adipogenic differentiation. At day 10 cells were analyzed. **(B)** Lipid accumulation was assessed by staining the cells with the lipophilic dye Nile Red. **(C)** mRNA expression of PPARγ was analyzed by qPCR and normalized to succinate dehydrogenase complex subunit A (SDHA) and related to control using the ΔΔCt method. **(D)** *In vitro* differentiated THP-1 macrophages were added to cultures of SGBS preadipocytes at increasing rates (THP-1:SGBS 1:10, 1:2, 1:1) during adipogenic differentiation. **(E)** Lipid accumulation was assessed by staining the cells with Nile Red. Nile Red signals of macrophage cultures were subtracted as background. Data are presented as mean + SEM of three independent experiments. \**p* \< 0.05.](fendo-02-00089-g002){#F2}

Also other insulin-dependent functions of the fat cell were characterized. As such, we showed in a previously published paper that macrophage-secreted factors inhibit insulin-stimulated glucose uptake by 65% (Keuper et al., [@B32]). Likewise, the *de novo* generation of triglycerides from glucose was decreased by 4.5-fold in the presence of macrophage-secreted factors. On the molecular level, macrophage-secreted factors caused a decrease in Akt phosphorylation, one of the key players in insulin signal transduction (Keuper et al., [@B32]).

Taken together, our human model system of inflamed adipose tissue showed the expected characteristics in terms of insulin sensitivity, i.e., an inhibition of adipogenic differentiation, a decrease in glucose uptake and lipogenesis and reduced phosphorylation of Akt.

Furthermore, the inflammatory micro-environment mimicked by MacCM induced a shift toward a pro-inflammatory adipocyte secretion profile. SGBS adipocytes were treated with MacCM or vehicle. After 24 h total mRNA was prepared and the expression of several target genes was analyzed by qPCR. The mRNA expression of adiponectin expression was robustly reduced (Figure [3](#F3){ref-type="fig"}A), while production of inflammatory chemokines and cytokines including MCP-1 (Figure [3](#F3){ref-type="fig"}B), interleukin-6 (IL6; Figure [3](#F3){ref-type="fig"}C), interleukin-8 (IL8; Figure [3](#F3){ref-type="fig"}D), and interleukin-1beta (IL1β; Figure [3](#F3){ref-type="fig"}E) was strongly increased.

![**Macrophage-conditioned medium (MacCM) differentially regulates adipokine expression**. SGBS adipocytes were incubated with medium, vehicle control, or 50% MacCM. After 24 h total RNA was prepared and reversely transcribed. Expression of adiponectin **(A)**, monocyte chemoattractant protein-1 (MCP-1) **(B)**, interleukin-6 (IL6) **(C)**, interleukin-8 (IL8) **(D)**, and interleukin-1beta (IL1β) **(E)** was analyzed by qPCR. The mRNA levels of target genes were normalized to those of succinate dehydrogenase complex subunit A (SDHA) using the ΔCt method and related to vehicle control using ΔΔCt method. Data are presented as mean + SEM of three independent experiments. \**p* \< 0.05.](fendo-02-00089-g003){#F3}

The Future -- Possibilities to Expand and Use the New Human *in vitro* System
=============================================================================

Our model system of human adipose tissue inflammation has been well characterized, but future efforts will help to further improve it. For example, cells lines could be replaced by primary cells if the identification of variations between patients is the main goal. As mentioned above SGBS cells were already successfully combined with primary isolated macrophages (Wentworth et al., [@B67]).

Additionally, model system like ours could be expanded with other important cell types found in obese adipose tissue. Interestingly, a close connection of T cells and the inflammatory process was reported. CD11c^+^ cells are responsible for the T cell infiltration and activation (Wu et al., [@B71]). The CD8^+^ T cell infiltration is linked to insulin resistance and obesity-associated inflammation (Kintscher et al., [@B33]; Nishimura et al., [@B43]). Recently, an important role for CD4^+^ T cells in the regulation of body weight, glucose tolerance, and insulin resistance was added to this picture (Winer et al., [@B69]). Since these studies implicate an important role for T cells in disease progression during diet-induced obesity, adding this cell type to our model might further enhance the system and the knowledge about their cellular and molecular interactions. Studies of murine CD8^+^ T cells in co-culture with adipocytes and macrophages showed an important role for CD8^+^ T cells in macrophage differentiation, migration, and activation (Nishimura et al., [@B43]). However, since we observed crucial differences between murine and human adipocytes this interplay has to be verified in a human model system.

Obesity is associated with endothelial dysfunction, a key early event in the initiation and progression of atherosclerosis (Steinberg et al., [@B56]). Endothelial dysfunction accompanies many of the obesity-associated disorders and is a predictor of future adverse cardiovascular events (Williams et al., [@B68]). Furthermore obesity is associated with dysregulated angiogenesis within the expanding adipose tissue (Halberg et al., [@B21]) suggesting a critical role for endothelial cells in this context. Endothelial cells isolated from human adipose tissue stimulate preadipocyte proliferation (Hutley et al., [@B28]). By incorporating endothelial cells into our system, interactions between human adipocytes and endothelial cells could be further elucidated and investigated in an inflammatory environment.

Importantly, SGBS adipocytes are suitable for culture in 96-well plates as well as 384-well plates allowing large-scale drug testing. As such, the SGBS:THP-1 co-culture system was successfully applied to study the effects of aleglitazar in a context of inflamed adipose tissue (Dzyakanchuk et al., [@B11]). Aleglitazar is a balanced dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, designed to optimize lipid and glycemic benefits (Dzyakanchuk et al., [@B11]).

Conclusion
==========

Taken together, our data suggest that THP-1 macrophages are able to create an inflammatory micro-environment very similar to the one found *in vivo*. SGBS adipocytes develop a phenotype of insulin resistance and their secretion profile undergoes a pro-inflammatory shift when exposed to this inflammatory environment. Therefore, we propose that this model system represents an excellent and easy-to-use opportunity to study molecular as well as cellular changes and effects in adipocytes in the context of an inflamed adipose tissue. Notably, this system also allows large-scale drug screening which might be very useful to find new compounds that ameliorate adipose tissue inflammation and/or restore normal adipocyte function despite inflammation.
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